These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 10989199)
1. Amelioration of severe hereditary spherocytosis in nonablated adult mice by marrow transplantation. Barker JE; Deveau S; Wandersee NJ Exp Hematol; 2000 Aug; 28(8):985-92. PubMed ID: 10989199 [TBL] [Abstract][Full Text] [Related]
2. Multiple high cell dose injections of normal marrow into newborn jaundiced mice dramatically prolong life despite transient repopulation. Barker JE; Kaysser-Kranich TM; Hamblen N; Deveau S Exp Hematol; 1999 May; 27(5):966-71. PubMed ID: 10340413 [TBL] [Abstract][Full Text] [Related]
3. Reduced incidence of thrombosis in mice with hereditary spherocytosis following neonatal treatment with normal hematopoietic cells. Wandersee NJ; Lee JC; Deveau SA; Barker JE Blood; 2001 Jun; 97(12):3972-5. PubMed ID: 11389042 [TBL] [Abstract][Full Text] [Related]
4. Thrombosis and secondary hemochromatosis play major roles in the pathogenesis of jaundiced and spherocytic mice, murine models for hereditary spherocytosis. Kaysser TM; Wandersee NJ; Bronson RT; Barker JE Blood; 1997 Dec; 90(11):4610-9. PubMed ID: 9373273 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of stem cell reserve using serial bone marrow transplantation and competitive repopulation in a murine model of chronic hemolytic anemia. Maggio-Price L; Wolf NS; Priestley GV; Pietrzyk ME; Bernstein SE Exp Hematol; 1988 Sep; 16(8):653-9. PubMed ID: 2900155 [TBL] [Abstract][Full Text] [Related]
6. Allo-hematopoietic stem cell transplantation is a potential treatment for a patient with a combined disorder of hereditary spherocytosis. Zhang XH; Fu HX; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Liu KY; Huang XJ Chin Med J (Engl); 2012 Mar; 125(5):947-50. PubMed ID: 22490603 [TBL] [Abstract][Full Text] [Related]
7. Murine hematopoietic stem cell distribution and proliferation in ablated and nonablated bone marrow transplantation. Zhong JF; Zhan Y; Anderson WF; Zhao Y Blood; 2002 Nov; 100(10):3521-6. PubMed ID: 12393430 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103 [TBL] [Abstract][Full Text] [Related]
9. Selective erythroid replacement in murine beta-thalassemia using fetal hematopoietic stem cells. Bethel CA; Murugesh D; Harrison MR; Mohandas N; Rubin EM Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10120-4. PubMed ID: 7980734 [TBL] [Abstract][Full Text] [Related]
10. Effect of systemic heparan sulfate haploinsufficiency on steady state hematopoiesis and engraftment of hematopoietic stem cells. Shekels LL; Buelt-Gebhardt M; Gupta P Blood Cells Mol Dis; 2015 Jun; 55(1):3-9. PubMed ID: 25976459 [TBL] [Abstract][Full Text] [Related]
11. Hematopoietic cells from -spectrin-deficient mice are sufficient to induce thrombotic events in hematopoietically ablated recipients. Wandersee NJ; Lee JC; Kaysser TM; Bronson RT; Barker JE Blood; 1998 Dec; 92(12):4856-63. PubMed ID: 9845553 [TBL] [Abstract][Full Text] [Related]
12. Transplantation of chromosomally marked syngeneic marrow cells into mice not subjected to hematopoietic stem cell depletion. Saxe DF; Boggs SS; Boggs DR Exp Hematol; 1984 May; 12(4):277-83. PubMed ID: 6370711 [TBL] [Abstract][Full Text] [Related]
13. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia. Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850 [TBL] [Abstract][Full Text] [Related]
14. [Recovery of vascular niche in bone marrow by donor derived endothelial progenitor cells after allogeneic bone marrow transplantation in mice]. Zhang Y; Song GL; Pan B; Hua J; Xu KL; Zeng LY Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):623-7. PubMed ID: 23134854 [TBL] [Abstract][Full Text] [Related]
15. Latent deficiency of the hematopoietic microenvironment of aged mice as revealed in W/Wv mice given +/+ cells. Boggs SS; Patrene KD; Austin CA; Vecchini F; Tollerud DJ Exp Hematol; 1991 Aug; 19(7):683-7. PubMed ID: 1893955 [TBL] [Abstract][Full Text] [Related]
17. Engraftment of splenic tissue as a method to investigate repopulation by hematopoietic cells from host and donor marrow. Shatry AM; Levy RB Stem Cells Dev; 2004 Aug; 13(4):390-9. PubMed ID: 15345133 [TBL] [Abstract][Full Text] [Related]
18. Marrow transplantation in the treatment of a murine heritable hemolytic anemia. Barker JE; McFarland-Starr EC Blood; 1989 May; 73(7):2014-7. PubMed ID: 2653468 [TBL] [Abstract][Full Text] [Related]
19. [Experimental study on rejection of allogeneic donor bone marrow cells in sensitized recipients]. Xu LH; Fang JP; Weng WJ; Xu HG; Ye QX Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):734-8. PubMed ID: 22339907 [TBL] [Abstract][Full Text] [Related]
20. Long-term maintenance of donor-derived hematopoiesis by intra-bone marrow-bone marrow transplantation. Omae M; Inaba M; Sakaguchi Y; Tsuda M; Miyake T; Fukui J; Iwai H; Yamashita T; Ikehara S Stem Cells Dev; 2008 Apr; 17(2):291-302. PubMed ID: 18447644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]